The patient presented with a large right renal mass who elected for right radical nephrectomy with possible inferior vena cava.
In this educational video, physicians from the Urology Department in the University of Kansas Health System demonstrate how to assemble a Thompson Retractor for midline transabdominal retroperitoneal surgery in a 68-year-old patient who presented with a large right renal mass and elected to receive right radical nephrectomy with possible inferior vena cava resection.
Transcript
In this video, we will discuss the importance of knowing how to properly assemble a Thompson surgical retractor before entering the operating room. As medical students and surgical residents, it's crucial to have a strong understanding of all surgical instruments, including retractors. The Thompson retractor is commonly used in various surgical procedures and is an essential tool for exposure of tissues.
A well-assembled retractor ensures that it functions as intended and minimizes the risk of injury to the patient. Additionally, perhaps underappreciated, being able to quickly and efficiently assemble a Thompson retractor can save valuable time during a surgery and improve overall surgical efficiency.
We will provide step-by-step instructions on how to properly assemble a Thompson retractor, including the placement of blades and handles. By the end of this video, it is our hope that you have a better understanding of the importance of knowing how to assemble a Thompson retractor and the impact it has on patient safety and surgical outcomes. So, let's get started and learn how to master this essential surgical tool.
Remember, patient safety should always be the top priority in the operating room and knowing how to properly use and assemble surgical instruments like the Thompson retractor is an important aspect of ensuring safe and successful surgeries.
Mitochondrial metabolism may promote kidney cancer metastasis, new data show
August 14th 2024“The challenge now is to understand how these key aspects of mitochondrial metabolism become activated, why they stimulate metastasis, and whether we can safely block them,” says Ralph J. DeBerardinis, MD, PhD.
Adding nivolumab to low-dose tivozanib does not improve PFS in renal cell carcinoma
July 19th 2024"While the addition of an ICI to low dose FOTIVDA did not improve PFS outcomes after prior ICI, we consider the control arm data an important, evidence-based and clinically meaningful contribution to the oncology community treating relapsed or refractory advanced RCC following front-line ICI combinations," says Michael P. Bailey.